Report Highlights
The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.
Report Includes
- 43 data tables and 66 additional tables
- An overview of the global markets for gastrointestinal disease (GI) therapeutics and diagnostics.
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028.
- Discussion of the current and future market potential for GI therapeutics and diagnostics, along with an analysis of the competitive environment, regulatory scenario, and technological advances.
- Estimate of the market size and revenue forecast for the global market, and corresponding market share analysis by diagnostics type, end user and region.
- Facts and figures pertaining to the major market dynamics, opportunities and deterrents, emerging technologies, future prospects and the impacts of macroeconomic variables.
- A look at the GI therapeutics and diagnostic options currently available as well as potential products and classes of products that are likely to have an impact.
- Discussion of sustainability trends and ESG developments, with an emphasis on consumer attitudes, analysis of companies’ ESG scores, and the ESG practices followed by leading companies.
- Information pertaining to the recent developments and emerging technologies in the market.
- Review of current and potential treatment options and their impact on this market growth.
- A look at the industry structure, competitive aspects of each product segment, increasing investment in R&D, market development strategies, and company value share analysis.
- An analysis of the competitive landscape based on recent developments and segmental revenues.
- Profiles of the major global players, including Takeda Pharmaceutical Co. Ltd., Johnson & Johnson Services Inc., AbbVie Inc., Sanofi, Bristol-Myers Squibb Co., and F. Hoffmann-La Roche Ltd.
Report Scope
This research study analyzes the GI diagnostics and therapeutics market, offers revenue forecasts, assesses future trends and provides strategic recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by product type and region from 2023 through 2028.
Report Synopsis
| Report Metrics | Details | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||||
| Forecast period considered | 2023-2028 | ||||||||||||
| Base year market size | $86.0 billion | ||||||||||||
| Market size forecast | $122.5 billion | ||||||||||||
| Growth rate | CAGR of 7.3% for the forecast period of 2023-2028 | ||||||||||||
| Units considered | $ Millions | ||||||||||||
| Segments covered | Drug Type, Disease Type, Product Type, and Region | ||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||
| Key Market Drivers |
|
||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.
Report Includes
- An overview of the global markets for gastrointestinal therapeutics and diagnostics.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
- Analyses of therapeutics currently on the market as well as potential products and classes of products that are likely to have a significant impact.
- Descriptions of the industry in detail, its relationship to the healthcare industry, its participants, and its trends for the future.
- Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities.
- Profiles of major players in the industry.
Report Highlights
- Overall sales in the gastrointestinal disorder treatment market amounted to $34.2 billionin 2007, and decreased slightly to $31.1 billion in 2009. By 2014, they are projected to reach $32.2 billion, for a 5-year compound annual growth rate (CAGR) of 0.7%.
- The largest segment of the market, prescription gastrointestinal drugs, was valued at $27.4 billion in 2008; this is expected to decrease to $26,3 billion in 2009, and to reach $27 billion in 2014, for a 5-year CAGR of 0.5%.
Report Highlights
-
The total U.S. market for gastrointestinal disorder treatments was estimated at $16.1 billion for 2004. Rising at an AAGR (average annual growth rate) of 7.3%, the market is expected to reach $22.8 billion in 2009.
-
The prescription market accounted for the largest percentage of sales with approximately 85%, or $13.7 billion in sales in for 2004. This segment is also rising the fastest, with an AAGR of 7.7%.
-
The OTC market accounts for the remaining 15%, or $2.4 billion. Rising at AAGR of 14%, it will represent only 13% of the market in 2009.
-
At approximately 80%, the largest area of market participation for leading competitors is within the prescription drug segment.
Related Reports
Global Bronchoscopy Market
The global bronchoscopy market should reach $3.9 billion by 2028 from $2.7 billion in 2023 at a compound annual growth rate (CAGR) of 7.4% for the forecast period of 2023 to 2028.
Endoscopy Devices: Applications and Global Markets
The global market for endoscopy devices is estimated to increase from $51.7 billion in 2022 to reach $75.9 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
Global Markets for Infectious Disease Treatments
The global market for infectious disease treatments should grow from $72.4 billion in 2021 to $106.3 billion by 2026, at compound annual growth rate (CAGR) of 8.0% for the period of 2021-2026.
Global Oncology Pharmaceuticals Market
The global market for oncology pharmaceuticals should grow from $177.4 billion in 2021 to $313.7 billion by 2026, at compound annual growth rate (CAGR) of 12.1% for the period of 2021-2026.
Recent Reports
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.
Global Markets and Technologies for Advanced Drug Delivery Systems
The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.
Global Markets for Vaccine Technologies
The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.
Chagas Disease: American trypanosomiasis Market
The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More